Oakes Benjamin L. bought SCTX
July 23, 2026 · Form 4 insider transaction
Oakes Benjamin L. bought 264,784 shares of Scribe Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
264,784
Price
$0.00
Total value
N/A
InsiderOakes Benjamin L.
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJuly 23, 2026
Filing dateJuly 27, 2026
Shares owned after264,784
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options will vest as to 1/48 of the total shares monthly over four years, with the first tranche scheduled to vest on August 23, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.